Centene Corp Del Stock Price, News & Analysis

Centene Corporation (NYSE: CNC) announced its financial guidance for 2021, projecting total revenues between $114.1 billion and $116.1 billion. Diluted EPS is expected to range from $3.82 to $4.06, and adjusted diluted EPS is forecasted at $5.00 to $5.30. The health benefits ratio is anticipated to be between 86.6% and 87.2%, with SG&A expense ratios of 8.8% to 9.3%. The 2020 revenue guidance remains confirmed at $109.8 billion to $111.4 billion, while diluted EPS guidance is updated to $3.08 to $3.18.

Centene Corporation (NYSE: CNC) announced a definitive agreement to acquire PANTHERx, a leading specialty pharmacy focused on orphan drugs and rare diseases. The acquisition, subject to regulatory approval, is expected to close by the end of 2020. PANTHERx enhances Centene's pharmacy portfolio by providing specialized compliance, logistics, and analytics solutions for patients with rare diseases. The partnership aims to improve care delivery and access to medications for complex conditions, furthering Centene's commitment to underserved populations.

QualChoice Health Insurance appointed Chris O'Dwyer as the new Director of Sales, effective Nov. 23, 2020. With a 28-year career in health insurance, O'Dwyer brings extensive experience from both brokerage and carrier sides, most recently at CIGNA. His deep knowledge and community connections are expected to enhance QualChoice's customer support and market presence in Arkansas. O'Dwyer's commitment to helping businesses find the best insurance options aligns with the company's mission.

Centene Corporation (NYSE: CNC) has successfully completed its acquisition of Apixio, a healthcare analytics firm specializing in AI technology solutions. This strategic move aims to enhance Centene's healthcare administration and foster innovation. Apixio will operate independently within Centene's Health Care Enterprises group, focusing on delivering value to clients while benefiting from Centene's scale. Centene, a Fortune 50 company, serves numerous healthcare programs, emphasizing quality, cost-effectiveness, and long-term growth.

Centene Corporation (NYSE: CNC) has appointed Brent Layton as Executive Vice President, Markets, Products, International, and Chief Business Development Officer, effective January 1, 2021. Layton, a 20-year veteran at Centene, aims to enhance strategic alignment across key markets and products. He will succeed Kenneth Burdick, who will retire on January 23, 2021 but will continue as a consultant through the year. This leadership change is expected to strengthen the company's growth trajectory and service delivery.

Centene Corporation (NYSE: CNC) announced a hybrid format for its upcoming 2021 Financial Guidance and Investor Meeting on December 18, 2020, due to rising COVID-19 cases in Missouri. The meeting will include pre-recorded management presentations and live Q&A sessions, prioritizing health and safety while ensuring transparent communication with investors. Centene, a leading healthcare enterprise, serves nearly 1 in 15 individuals in the U.S. through various government-sponsored programs and healthcare services. Additional meeting details will be available on the company's investor relations website.

Health Net has achieved impressive ratings for its Medicare Advantage plans in California, receiving a 4-out-of-5 Star rating from the Centers for Medicare & Medicaid Services (CMS) for 2021. This marks the third consecutive year Health Net has secured a rating of 4 Stars or higher, highlighting its commitment to delivering quality healthcare. With its extensive network of providers, Health Net serves over 3 million members across California and continues to enhance its service offerings in multiple counties. The Medicare Annual Enrollment Period is ongoing until Dec. 7, 2020.

Centene Corporation (NYSE: CNC) announced a virtual 2021 Financial Guidance and Investor Meeting scheduled for December 18, 2020. Led by Michael F. Neidorff, the meeting will be streamed live on the company's website. Participants can look forward to detailed insights on financial strategies and growth outlook. Centene is a leading healthcare enterprise that serves nearly 1 in 15 individuals in the U.S., offering integrated services for Medicaid, Medicare, and more. The investor relations website will provide additional information for investors.

Centene Corporation (NYSE: CNC) shows its commitment to rural healthcare on National Rural Health Day by partnering with the National Organization of State Offices of Rural Health. This initiative aims to address healthcare challenges faced in rural areas, where residents experience higher mortality rates and more preventable admissions. Centene is enhancing access through telehealth solutions, including providing smartphones to providers and facilitating broadband services. The company emphasizes its dedication to ensuring quality healthcare access for vulnerable populations, particularly during the COVID-19 pandemic.